Index of reports
> Disability (71)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pegasys (Peginterferon Alfa-2A) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 71 Next >>
Possible Pegasys side effects in
Reported by a pharmacist from United States on 2012-08-23
Patient:
Reactions: Dyspnoea, Chest Discomfort, Anaemia, Blood Pressure Decreased, Asthenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Start date: 2012-05-16
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-05-16
Victrelis
Dosage: 200 mg, tid
Administration route: Oral
Start date: 2012-06-27
End date: 2012-07-03
Other drugs received by patient: Imdur; Aspirin; Calcium 500; Vitamin B Complex CAP; Metoprolol Tartrate; Hydralazine HCL; Fish OIL; Tricor; Cardura; Procardia XL; Lasix
Possible Pegasys side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 65.4 kg (143.8 pounds)
Reactions: Renal Failure
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Incivek
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Pegasys
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Other drugs received by patient: Zantac; Lisinopril; Ramipril
Possible Pegasys side effects in male
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-16
Patient: male
Reactions: Drug Ineffective, Deafness Unilateral, Dizziness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-07-20
Victrelis
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-20
Possible Pegasys side effects in male
Reported by a physician from Australia on 2012-08-14
Patient: male, weighing 88.0 kg (193.6 pounds)
Reactions: Deafness Neurosensory
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-24
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-28
Other drugs received by patient: Fungilin; Pristiq
Possible Pegasys side effects in female
Reported by a physician from Israel on 2012-08-13
Patient: female
Reactions: Neuropathy Peripheral, Cryoglobulinaemia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Copegus
Dosage: date of last dose prior to sae: 20/feb/2012
Indication: Hepatitis C
Start date: 2011-03-27
End date: 2012-02-20
Pegasys
Dosage: date of last dose prior to sae: 20/feb/2012
Indication: Hepatitis C
Start date: 2011-03-27
End date: 2012-02-20
Other drugs received by patient: Levothyroxine Sodium; Betacorten; Brimonidine Tartrate
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-10
Patient:
Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Copegus
Dosage: 400-800 mg
Administration route: Oral
Pegasys
Victrelis
Administration route: Oral
Other drugs received by patient: Doxycycline HCL
Possible Pegasys side effects in male
Reported by a physician from United States on 2012-08-02
Patient: male, weighing 67.0 kg (147.4 pounds)
Reactions: Pericarditis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2011-07-08
Copegus
Start date: 2012-06-04
Pegasys
Dosage: reduced dosage
Start date: 2012-03-20
End date: 2012-05-28
Pegasys
Start date: 2012-05-28
Pegasys
Dosage: reduced dosage
Start date: 2012-02-06
End date: 2012-03-20
Pegasys
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2012-02-06
RO 5466731 (Hcv Ns5b Inhibitor)
Dosage: loading dose
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2012-06-04
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient:
Reactions: Polyneuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Copegus
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-03-14
Pegasys
Dosage: 130 microgram, unk
Indication: Hepatitis C
Start date: 2012-01-01
End date: 2012-03-14
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-29
End date: 2012-03-14
Possible Pegasys side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female, weighing 64.5 kg (141.9 pounds)
Reactions: Emotional Distress
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Blinded RO 5466731 (Hcv Ns5b Inhibitor)
Indication: Hepatitis C
Start date: 2011-06-07
End date: 2011-08-24
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-06-07
End date: 2011-08-24
Pegasys
Indication: Hepatitis C
Start date: 2011-06-07
End date: 2011-08-24
Other drugs received by patient: Vitamin D; Advil; Nexium; Lamotrigine
Possible Pegasys side effects in male
Reported by a physician from France on 2012-07-27
Patient: male
Reactions: Polyneuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Start date: 2012-01-01
End date: 2012-03-14
Copegus
Indication: Product Used FOR Unknown Indication
Pegasys
Start date: 2012-01-01
End date: 2012-03-14
Pegasys
Indication: Product Used FOR Unknown Indication
Victrelis
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-29
End date: 2012-03-14
Possible Pegasys side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient: female
Reactions: Confusional State, Disorientation
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribasphere
Indication: Product Used FOR Unknown Indication
Victrelis
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
Possible Pegasys side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-20
Patient: 62 year old female
Reactions: Confusional State, Activities of Daily Living Impaired, Disorientation
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg, capsule, three times a day, oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
Possible Pegasys side effects in male
Reported by a physician from Germany on 2012-07-19
Patient: male, weighing 73.0 kg (160.6 pounds)
Reactions: Germ Cell Cancer
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-20
End date: 2012-03-03
Pegasys
Indication: Hepatitis C
Start date: 2011-10-19
End date: 2012-03-03
Other drugs received by patient: Methadone HCL
Possible Pegasys side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-19
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Adverse Event
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Incivek
Dosage: 2 tablets 7-9 hrs apart
Pegasys
Indication: Hepatitis C
Start date: 2011-09-03
End date: 2012-05-13
Pegasys
Indication: Disease Recurrence
Start date: 2011-09-03
End date: 2012-05-13
Ribavirin
Dosage: (6) a day
Victrelis
Dosage: 12 a day
Possible Pegasys side effects in male
Reported by a physician from Japan on 2012-07-10
Patient: male
Reactions: Blood Pressure Increased, Malaise, Cerebral Haemorrhage
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Mircera
Indication: Nephrogenic Anaemia
Start date: 2012-05-01
Pegasys
Dosage: dosage is uncertain.
Indication: Hepatitis C
Start date: 2011-10-07
Possible Pegasys side effects in male
Reported by a physician from United States on 2012-07-05
Patient: male, weighing 67.0 kg (147.4 pounds)
Reactions: Pericarditis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2011-07-08
Copegus
Start date: 2012-06-04
Pegasys
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2012-02-06
Pegasys
Dosage: reduced dosage
Start date: 2012-02-06
End date: 2012-05-28
Pegasys
Start date: 2012-05-28
RO 5466731 (Hcv Ns5b Inhibitor)
Dosage: loading dose
Indication: Hepatitis C
Start date: 2011-07-08
End date: 2012-06-04
Possible Pegasys side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: male
Reactions: Dysgeusia, Chest Discomfort, Dyspnoea, Fatigue, Nausea, Anaemia, Chest Pain
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribasphere
Indication: Product Used FOR Unknown Indication
Victrelis
Administration route: Oral
Indication: Hepatitis C
Possible Pegasys side effects in 53 year old male
Reported by a pharmacist from Canada on 2012-06-26
Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)
Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Pegasys side effects in 60 year old male
Reported by a pharmacist from United States on 2012-06-26
Patient: 60 year old male
Reactions: Angioedema
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg;qw;
Indication: Hepatitis C
Ribavirin
Dosage: 500 mg;bid;
Indication: Hepatitis C
Victrelis
Dosage: 800 mg;q8h; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-04
Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril
Possible Pegasys side effects in male
Reported by a physician from Germany on 2012-06-25
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Retinal Vein Occlusion, Macular Oedema
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
Copegus
Indication: Hepatitis C
Start date: 2011-09-29
Pegasys
Indication: Hepatitis C
Start date: 2011-09-29
Possible Pegasys side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13
Patient: 51 year old female
Reactions: Dysgeusia, Mental Impairment, Hepatic Pain, Fatigue, Anaemia, Influenza Like Illness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Dosage: 80 mcg
Indication: Product Used FOR Unknown Indication
Ribasphere
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-01
Possible Pegasys side effects in 50 year old male
Reported by a consumer/non-health professional from Germany on 2012-06-11
Patient: 50 year old male, weighing 84.0 kg (184.8 pounds)
Reactions: Bronchitis Bacterial, Anaemia, Pancytopenia, Myocardial Infarction, Acute Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Boceprevir
Start date: 2012-02-14
End date: 2012-03-26
Boceprevir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-14
End date: 2012-03-26
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-14
End date: 2012-03-26
Copegus
Dosage: 400-800 mg
Start date: 2012-01-14
End date: 2012-03-26
Pegasys
Indication: Hepatitis C
Start date: 2012-01-14
End date: 2012-03-21
Other drugs received by patient: Doxycycline
Possible Pegasys side effects in male
Reported by a physician from Spain on 2012-06-08
Patient: male
Reactions: Erectile Dysfunction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-02-25
End date: 2011-09-07
Ribavirin
Dosage: dosage: 1200 units not reported
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-02-25
End date: 2011-09-07
Possible Pegasys side effects in female
Reported by a individual with unspecified qualification from United States on 2012-06-07
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: B-Cell Lymphoma Stage IV, Pneumonia, Pulmonary Vasculitis, Pancytopenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-16
End date: 2011-04-27
Copegus
Start date: 2011-07-05
End date: 2011-07-05
Copegus
Administration route: Oral
Start date: 2011-04-27
End date: 2011-05-10
Copegus
Start date: 2011-07-05
Copegus
Administration route: Oral
Start date: 2011-05-10
End date: 2011-07-05
Pegasys
Start date: 2011-04-20
End date: 2011-06-29
Pegasys
Start date: 2011-06-29
Pegasys
Indication: Hepatitis C
Start date: 2011-03-16
End date: 2011-04-20
Pegasys
Start date: 2011-06-29
End date: 2011-06-29
RO 5466731 (Hcv Ns5b Inhibitor)
Dosage: date of dicontinuation: 05/jul/2011
Indication: Hepatitis C
Start date: 2011-03-16
End date: 2011-07-05
Other drugs received by patient: Spironolactone; Lasix; RED Cells Pack; Lortab; Lasix; Rabeprazole Sodium; Alprazolam; Diphenhydramine HCL; Protonix; Lithium Carbonate; Promethazine; Zolpidem; Epoetin Alfa; Acetaminophen
Possible Pegasys side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-04
Patient: 62 year old male
Reactions: Dysgeusia, Fatigue, Chest Discomfort, Dyspnoea, Nausea, Anaemia, Chest Pain
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribasphere
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Possible Pegasys side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-02
Patient: 55 year old female
Reactions: Dysgeusia, Fatigue, Nausea, Anaemia, Gastrooesophageal Reflux Disease
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-04-01
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Possible Pegasys side effects in male
Reported by a physician from Australia on 2012-05-31
Patient: male, weighing 88.0 kg (193.6 pounds)
Reactions: Deafness Bilateral
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-24
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-12
End date: 2012-01-28
Other drugs received by patient: Fungilin; Pristiq
Possible Pegasys side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: male
Reactions: Gait Disturbance
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Victrelis
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-13
End date: 2012-04-01
Possible Pegasys side effects in 60 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23
Patient: 60 year old male
Reactions: Listless, Nausea, Anaemia, Rash, Abdominal Discomfort, Subretinal Haematoma, Syncope, Fatigue, Gastrointestinal Disorder, Insomnia, Vision Blurred, Dizziness
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Victrelis
Dosage: 800 mg; tid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-28
End date: 2012-04-30
Other drugs received by patient: Nadolol
Possible Pegasys side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient: 58 year old male
Reactions: Arthralgia, Hypotension, Dizziness, Headache, Asthenia, Blood Pressure Diastolic Decreased, Abdominal Pain Upper
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Norvasc
Dosage: 10 mg;qd
Indication: Product Used FOR Unknown Indication
Pegasys
Dosage: 180 mcg;qw
Indication: Hepatitis C
Start date: 2012-03-22
Ribasphere
Dosage: 1000 mg;bid
Indication: Hepatitis C
Start date: 2012-03-22
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Other drugs received by patient: Benazepril Hydrochloride W / Hydrochlorothiaz.
Page 1 Next >>
|